Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential?
Collen
D
D
Center for Molecular and Vascular Biology, University of Leuven, Belgium.
Lijnen
H R
HR
D000818:Animals; D004789:Enzyme Activation; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000737:chemistry / Q000276:immunology / Q000493:pharmacokinetics; D005798:Genes, Bacterial; D008666:Metalloendopeptidases / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000493:pharmacokinetics / Q000627:therapeutic use; D010958:Plasminogen / Q000378:metabolism; D011817:Rabbits; D011994:Recombinant Proteins; D013211:Staphylococcus aureus / Q000737:chemistry / Q000235:genetics; D013927:Thrombosis / Q000188:drug therapy; D000979:alpha-2-Antiplasmin / Q000378:metabolism
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D000979:alpha-2-Antiplasmin; D005337:Fibrin; D010958:Plasminogen; D005341:Fibrinolysin; D008666:Metalloendopeptidases; C022653:auR protein, Staphylococcus aureus